These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14864943)

  • 21. [Comparative sensitivity of clinical strains of gram-positive and gram-negative microorganisms to antibacterial antibiotics].
    Nekhorosheva AG; Khantimer EI
    Antibiot Med Biotekhnol; 1986 Apr; 31(4):291-4. PubMed ID: 3717927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effect of combinations of antimicrobial agents and EDTA-tromethamine on certain gram-positive bacteria.
    Wooley RE; Jones MS; Gilbert JP; Shotts EB
    Am J Vet Res; 1983 Nov; 44(11):2167-9. PubMed ID: 6418038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vitamin inhibition of antibiosis by metabolic antagonism. Research in vitro on Staph. aureus with terramycin and tyrothricin].
    DI RAIMONDO F; MANNINO N; ORABONA ML
    Boll Ist Sieroter Milan; 1953; 32(1-2):45-51. PubMed ID: 13059079
    [No Abstract]   [Full Text] [Related]  

  • 24. Biofilm bacteria: formation and comparative susceptibility to antibiotics.
    Olson ME; Ceri H; Morck DW; Buret AG; Read RR
    Can J Vet Res; 2002 Apr; 66(2):86-92. PubMed ID: 11989739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteria.
    Smith RP; Baltch AL; Hammer MC; Conroy JV
    Clin Ther; 1986; 9(1):106-18. PubMed ID: 3815456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights.
    Masschelein J; Jenner M; Challis GL
    Nat Prod Rep; 2017 Jul; 34(7):712-783. PubMed ID: 28650032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of betamethasone in combination with antibiotics on gram positive and gram negative bacteria.
    Artini M; Papa R; Cellini A; Tilotta M; Barbato G; Koverech A; Selan L
    Int J Immunopathol Pharmacol; 2014; 27(4):675-82. PubMed ID: 25572750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro sensitivity to terramycin of bacteria isolated from small animals.
    LEBEAU LJ; BOND E; BANICKI J; NOVAK M
    Cornell Vet; 1952 Apr; 42(2):200-6. PubMed ID: 14926330
    [No Abstract]   [Full Text] [Related]  

  • 29. Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria.
    Uppu DSSM; Konai MM; Sarkar P; Samaddar S; Fensterseifer ICM; Farias-Junior C; Krishnamoorthy P; Shome BR; Franco OL; Haldar J
    PLoS One; 2017; 12(8):e0183263. PubMed ID: 28837596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationalizing the permeation of polar antibiotics into Gram-negative bacteria.
    Scorciapino MA; Acosta-Gutierrez S; Benkerrou D; D'Agostino T; Malloci G; Samanta S; Bodrenko I; Ceccarelli M
    J Phys Condens Matter; 2017 Mar; 29(11):113001. PubMed ID: 28155846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
    Briers Y; Lavigne R
    Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A new conquest in the field of antibiotics: terramycin].
    Athena; 1950 Dec; 16(12):291. PubMed ID: 14800796
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic].
    Inoue E; Komoto E; Taniyama Y; Mitsuhashi S
    Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A note on the use of antibiotics in the treatment of infections with some gram-negative bacilli.
    KEATING SV
    Med J Aust; 1951 Nov; 2(21):709-10. PubMed ID: 14899117
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analysis of predominant bacteria of burn infection and their resistance to antibiotics in recent years].
    Li M; Zhang GA; Liu Y
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):91-3. PubMed ID: 17649879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Problem of temperature relationship of antibiotics against gram-negative intestinal bacteria].
    KNOTHE H; BUTENBERG O
    Z Hyg Infektionskr; 1955; 141(4):315-25. PubMed ID: 13257401
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs.
    Stepanović S; Antić N; Dakić I; Svabić-Vlahović M
    Microbiol Res; 2003; 158(4):353-7. PubMed ID: 14717457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.
    Dubourg G; Okdah L; Le Page S; Rolain JM; Raoult D
    Int J Antimicrob Agents; 2015 Dec; 46(6):718-20. PubMed ID: 26589488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.